RLAY Latest Headlines

Mid-cap healthcare stocks ranked by quant ratings after earnings season

at seekingalpha.com (Tue, 26-May 10:10 AM)

Guggenheim Keeps Their Buy Rating on Relay Therapeutics (RLAY)

at www.tipranks.com (Tue, 26-May 7:04 AM)

SA Asks: What are the most attractive biotech stocks right now?

at seekingalpha.com (Sun, 24-May 4:13 PM)

Relay Therapeutics’ $275 Million Offering: What the Major Capital Raise Signals for RLAY

Market Chameleon (Thu, 21-May 10:32 AM)

Relay Therapeutics' $275 Million Offering Bolsters Pipeline Ambitions—Key Details for Investors

Market Chameleon (Thu, 21-May 8:15 AM)

Relay Therapeutics' Zovegalisib Shows 60% Early Response Rate in Rare Vascular Anomaly Trial

Market Chameleon (Tue, 19-May 10:11 AM)

Zovegalisib Shows 60% Initial Response Rate in Relay Therapeutics’ Phase 2 Trial—Safety Profile Also Supports Chronic Use

Market Chameleon (Tue, 19-May 7:05 AM)

Relay Therapeutics Highlights Strong Efficacy and Tolerability for Zovegalisib at Phase 3 Dose in PI3Ka-Mutant Breast Cancer

Market Chameleon (Mon, 16-Mar 7:53 AM)

Relay Therapeutics Poised for Impact as Biliary Tract Cancer Market Set for 10.1% CAGR Growth Through 2034

Market Chameleon (Tue, 3-Mar 7:42 AM)